- জেনেরিক নাম
- Favipiravir
- শক্তি
- 200 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Biopharma Ltd.
৳ ১৯৬ ৳ ২০০.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Biofavi হলো Favipiravir-এর একটি ব্র্যান্ড, শক্তি ২০০ mg, ট্যাবলেট আকারে। তালিকাভুক্ত প্রতি ইউনিটের দাম ৪০০ টাকা। Biofavi প্রস্তুত করেছে Biopharma Ltd। Favipiravir-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Favipiravir-এর ৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Biofavi এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি। সবচেয়ে কম দাম Favivir 200 mg Tablet-এর, প্রতি ইউনিট ৳ ২০০.০০।
Biofavi 200 mg Tablet is an antiviral medicine whose active ingredient is favipiravir. It belongs to the antiviral drug group and is prescribed for treating novel or re-emerging pandemic influenza virus infections, limited to cases where other influenza antiviral drugs are ineffective or not sufficiently effective. It works by blocking an enzyme the influenza virus needs to copy itself. Biofavi comes as a tablet in a 200 mg strength, supplied by Biopharma Ltd. in a 2 x 10 pack. Only a registered doctor can decide whether it is suitable for a particular patient.
Biofavi 200 mg Tablet is used to treat novel or re-emerging pandemic influenza virus infections. Its use is limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective. It is an antiviral medicine, not a general remedy for colds or other infections. A doctor assesses the infection and decides whether this medicine is appropriate. Do not start it on your own.
Take Biofavi 200 mg Tablet exactly as your registered doctor directs. The dose, the number of times a day and the length of the course are decided by the doctor and may differ from person to person. Swallow the tablet as advised. Do not change the dose or stop early on your own, and ask your doctor or pharmacist if you are unsure how to take it.
The most common side effects of favipiravir are diarrhea and a rise in blood uric acid levels. Blood uric acid changes are usually found through tests, so your doctor may monitor you. Contact your doctor if diarrhea is troublesome or if you notice any unusual symptom. Ask your doctor or pharmacist about anything you are worried about while taking Biofavi 200 mg Tablet.
Biofavi 200 mg Tablet must not be used during pregnancy, and women who may possibly be pregnant should not take it. Before use, women who could become pregnant need confirmation that they are not pregnant, and effective contraception is required from the start of treatment until a period after the end of treatment as advised by the doctor. Tell your doctor if you have liver or kidney problems. Keep the medicine below 30°C, protected from light and moisture, and out of reach of children.
Biofavi is a tablet, which is a solid dosage form you swallow. The strength is 200 mg, meaning each tablet contains 200 mg of favipiravir. The pack is 2 x 10. Your doctor decides how the tablet is used in your case.
It is an antiviral medicine containing favipiravir. It is used for novel or re-emerging pandemic influenza virus infections, limited to cases where other influenza antiviral drugs are ineffective or not sufficiently effective. A doctor decides if it is right for you.
The most common side effects are diarrhea and an increase in blood uric acid levels. Call your doctor if diarrhea is troublesome or if you notice any unusual symptom. Ask your doctor or pharmacist about any concern while taking this medicine.
The listed price is ৳ ২০০.০০.
৳ ১৯৬ ৳ ২০০.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Treatment of novel or re-emerging pandemic influenza virus infections (limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective).এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Favipiravir is a new antiviral drug against influenza. It is metabolized into favipiravir ribosyl triphosphate (favipiravir RTP) by an intracellular enzyme, and favipiravir RTP selectively inhibits RNA polymerase (RNA-dependent RNA polymerase) of the influenza virus, preventing replication of the influenza virus. It is a drug with a mechanism of action different from that of the existing influenza antiviral drugs and effective against all types and sub-types of human influenza A, B, and C viruses in vitro, showing a wide range of anti-viral activity against various influenza virus strains including avian and swine viruses.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The usual adult dosage is 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5 or as directed by physicians. The total treatment duration should be 5 days.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Favipiravir in humans is not readily available.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Favipiravir is contraindicated for pregnant women and women who may possibly be pregnant.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Most common side effects are Diarrhea and increase of blood uric acid levels.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Favipiravir may cause delayed development or death of embryos during the early stage of pregnancy. Should not be given during pregnancy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Favipiravir should not be given in pregnant women, requirement of the confirmation of non-pregnancy in women of childbearing potential before use, thorough contraception measures from the start of the treatment to 7 days after the end of the treatment. Caution should be taken for Hepatic and renal impaired patient or use Favipiravir as per the direction of registered Physicianএই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Favipiravir in humans is not readily available.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।